Abstract
Purpose
Hepatitis B and C are important and relatively common health issues. It is known that many patients who underwent total knee and hip arthroplasty were also diagnosed with hepatitis. These patients are at higher risk of periprosthetic joint infection (PJI). This study aimed to investigate the differences in PJI cases in hepatitis B and C patients.
Methods
This is a retrospective case-controlled single-center study. A total of 270 patients with hepatitis and non-hepatitis (control group) who underwent one-stage septic exchange to the hip and knee joints were included in the study. All patients' previous surgical histories, infective organisms, C-reactive protein (CRP) values before septic exchange, and demographic data were evaluated. All microbiological and laboratory evaluations were performed separately for knee and hip arthroplasty.
Results
The mean CRP levels of Hep B- and C-positive patients, who underwent one-stage septic exchange in the knee joint, were 23.6 mg/L. In the control group, this value was 43.1 mg/L and a statistically significant difference was found between the groups (p = 0.004). Gram-negative organisms were identified in a larger proportion of patients with hepatitis who developed PJI in both hip and knee joints and underwent one-stage septic exchange (p = 0.041/p = 0.044).
Conclusion
PJIs caused by Gram-negative bacteria are encountered more frequently in patients with hepatitis than in the control group. In addition, the CRP rise is less in patients with hepatitis compared to PJI cases in the control group. Patient-specific evaluation is required in cases of PJI in patient groups with co-existing hepatitis.
Similar content being viewed by others
Availability of data and materials
The data that support the findings of this study are available on request from the corresponding author [MC]. The data are not publicly available, because their containing information that could compromise the privacy of research participants.
References
McDermott KW, Liang L (2006) Overview of operating room procedures during inpatient stays in U.S. hospitals, 2018: statistical brief #281. Healthcare cost and utilization project (HCUP) statistical briefs
Singh JA, Yu S, Chen L, Cleveland JD (2019) Rates of total joint replacement in the United States: future projections to 2020–2040 using the national inpatient sample. J Rheumatol 46:1134–1140. https://doi.org/10.3899/JRHEUM.170990
Kildow BJ, Politzer CS, DiLallo M et al (2018) Short and long-term postoperative complications following total joint arthroplasty in patients with human immunodeficiency virus, hepatitis B, or hepatitis C. J Arthroplasty 33:S86–S92.e1. https://doi.org/10.1016/J.ARTH.2017.10.061
Schweitzer A, Horn J, Mikolajczyk RT et al (2015) Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386:1546–1555. https://doi.org/10.1016/S0140-6736(15)61412-X
Gower E, Estes C, Blach S et al (2014) Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 61:S45–S57. https://doi.org/10.1016/J.JHEP.2014.07.027
Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med. https://doi.org/10.1056/NEJMRA040181
Kapadia BH, Berg RA, Daley JA et al (2016) Periprosthetic joint infection. Lancet 387:386–394. https://doi.org/10.1016/S0140-6736(14)61798-0
Akgün D, Wiethölter M, Siegert P et al (2022) The role of serum C-reactive protein in the diagnosis of periprosthetic shoulder infection. Arch Orthop Trauma Surg 142:1715–1721. https://doi.org/10.1007/S00402-021-03779-2
Sproston NR, Ashworth JJ (2018) Role of C-reactive protein at sites of inflammation and infection. Front Immunol. https://doi.org/10.3389/FIMMU.2018.00754
Wang J, Zhao G, Chen J et al (2019) Association of hepatitis B infection with high-risk complications in total joint arthroplasty. BMC Musculoskelet Disord. https://doi.org/10.1186/S12891-019-2535-Y
Parvizi J, Tan TL, Goswami K et al (2018) The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria. J Arthroplasty 33:1309-1314.e2. https://doi.org/10.1016/J.ARTH.2018.02.078
Jenne CN, Kubes P (2013) Immune surveillance by the liver. Nat Immunol 14:996–1006. https://doi.org/10.1038/NI.2691
Sandler NG, Koh C, Roque A et al (2011) Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology. https://doi.org/10.1053/J.GASTRO.2011.06.063
Brandolini M, Corbella M, De Silvestri A et al (2015) Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease. Infection 43:561–567. https://doi.org/10.1007/S15010-015-0794-6
Parker R, Im G, Jones F et al (2017) Clinical and microbiological features of infection in alcoholic hepatitis: an international cohort study. J Gastroenterol 52:1192–1200. https://doi.org/10.1007/S00535-017-1336-Z
Zhai XR, Tong JJ, Wang HM et al (2020) Infection deteriorating hepatitis B virus related acute-on-chronic liver failure: a retrospective cohort study. BMC Gastroenterol. https://doi.org/10.1186/S12876-020-01473-Y
Bjerke-Kroll BT, Christ AB, McLawhorn AS et al (2014) Periprosthetic joint infections treated with two-stage revision over 14 years: an evolving microbiology profile. J Arthroplasty 29:877–882. https://doi.org/10.1016/J.ARTH.2013.09.053
Tsai JC, Sheng WH, Lo WY et al (2015) Clinical characteristics, microbiology, and outcomes of prosthetic joint infection in Taiwan. J Microbiol Immunol Infect 48:198–204. https://doi.org/10.1016/J.JMII.2013.08.007
Villa JM, Pannu TS, Theeb I et al (2021) International organism profile of periprosthetic total hip and knee infections. J Arthroplasty 36:274–278. https://doi.org/10.1016/J.ARTH.2020.07.020
Bosco F, Cacciola G, Giustra F et al (2023) Characterizing recurrent infections after one-stage revision for periprosthetic joint infection of the knee: a systematic review of the literature. Eur J Orthop Surg Traumatol. https://doi.org/10.1007/S00590-023-03480-7
Zimmerli W, Sendi P (2017) Orthopaedic biofilm infections. APMIS 125:353–364. https://doi.org/10.1111/APM.12687
Tande AJ, Patel R (2014) Prosthetic joint infection. Clin Microbiol Rev 27:302–345. https://doi.org/10.1128/CMR.00111-13
Benito N, Mur I, Ribera A et al (2019) The different microbial etiology of prosthetic joint infections according to route of acquisition and time after prosthesis implantation, including the role of multidrug-resistant organisms. J Clin Med. https://doi.org/10.3390/JCM8050673
Tai DBG, Patel R, Abdel MP et al (2022) Microbiology of hip and knee periprosthetic joint infections: a database study. Clin Microbiol Infect 28:255–259. https://doi.org/10.1016/J.CMI.2021.06.006
Parvizi J, Gehrke T (2014) Definition of periprosthetic joint infection. J Arthroplasty 29:1331. https://doi.org/10.1016/J.ARTH.2014.03.009
Saleh A, George J, Faour M et al (2018) Serum biomarkers in periprosthetic joint infections. Bone Jt Res 7:85–93. https://doi.org/10.1302/2046-3758.71.BJR-2017-0323
Kuo SJ, Huang PH, Chang CC et al (2016) Hepatitis B virus infection is a risk factor for periprosthetic joint infection among males after total knee arthroplasty: a Taiwanese nationwide population-based study. Medicine. https://doi.org/10.1097/MD.0000000000003806
Baek JH, Lee SC, Ryu S et al (2022) Long-term outcomes of primary total knee arthroplasty in patients with hepatitis B virus infection. Bone Jt Open 3:470–474. https://doi.org/10.1302/2633-1462.36.BJO-2022-0030.R1
Ross BJ, Cole MW, Ross AJ et al (2023) Hepatitis C is associated with higher short-term complication rates after initial aseptic and septic revision total hip arthroplasty: a matched cohort study. J Arthroplasty 38:548–554. https://doi.org/10.1016/J.ARTH.2022.09.018
Salter ML, Lau B, Mehta SH et al (2013) Correlates of elevated interleukin-6 and C-reactive protein in persons with or at high risk for HCV and HIV infections. J Acquir Immune Defic Syndr 64:488–495. https://doi.org/10.1097/QAI.0B013E3182A7EE2E
Shah S, Ma Y, Scherzer R et al (2015) Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels. AIDS 29:1325–1333. https://doi.org/10.1097/QAD.0000000000000654
Marnell L, Mold C, Du Clos TW (2005) C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 117:104–111. https://doi.org/10.1016/J.CLIM.2005.08.004
Funding
There is no funding for this study.
Author information
Authors and Affiliations
Contributions
The authors’ contribution to the manuscript is declared in detail in the following: conceptualization—MA, MC; methodology—MA, SA, FLP, MC; validation—all authors; formal analysis—SA, MA.; writing—original draft preparation—MA, SA, NS; review and editing—all authors; visualization—NS, MA, TG; supervision—MC, TG; project administration—MC. All authors have read and agreed to the final version of this manuscript. All authors have approved the submission of this manuscript. The authors declare that the manuscript in its current (or in any other) form has not been published previously, is not under consideration for publication in another journal at this time, and will not be published anywhere else in this form or following translation.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest regarding this manuscript. Independent from the submitted manuscript, received royalities/payments of all authors are listed: payments for presentations from Waldemar Link, Hamburg, Germany. Zimmer Biomet Inc., Warsaw, USA. Heraeus. Ceramtec Co.
Ethical approval
The study design was approved by the local ethics committee (2021-300086_1-WF and informed consent was obtained from each patient.
Consent to publish and participate
All patients gave informed consent to participate in the study, and agreed having their data published in a journal article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Akkaya, M., Akcaalan, S., Perrone, F.L. et al. Organism profile and C-reactive protein (CRP) response are different in periprosthetic joint infection in patients with hepatitis. Arch Orthop Trauma Surg 144, 341–346 (2024). https://doi.org/10.1007/s00402-023-05059-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00402-023-05059-7